CM336 Plus Isatuximab for Newly Diagnosed Multiple Myeloma With Severe Renal Impairment

NCT07585760 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma (MM)
Multiple Myeloma Light Chain Induced Renal Insufficiency

Interventions

DRUG: CM336 Plus Isatuximab

Sponsor

Institute of Hematology & Blood Diseases Hospital, China